Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing brinzolamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brinzolamide (substance) |
Inferred relationship |
Some |
|
Brinzolamide 1% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brinzolamide (substance) |
Inferred relationship |
Some |
|
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing brinzolamide in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing only brinzolamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Brinzolamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brinzolamide 10 milligram/1 milliliter conventional release suspension for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
1 |
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only brimonidine and brinzolamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brimonidine and brinzolamide only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brimonidine- and brinzolamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brimonidine- and brinzolamide-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brinzolamide- and timolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Product containing brinzolamide and timolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brinzolamide and timolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Product containing only brinzolamide and timolol in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brinzolamide 10 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |
Brinzolamide 10 mg/mL and timolol (as timolol maleate) 5 mg/mL eye drops suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brinzolamide (substance) |
Inferred relationship |
Some |
2 |